The inhibition of DAT increased synaptic plasticity in hippocampus and enhanced transsynaptic levels of DA in the PFC, which could reverse depressive‐like behaviors and restore motivational deficiencies appearing in depression.45 The gene discussed is SLC6A3; the disease is depressive symptom measurement.